Digestive Health Stocks
Biopharmaceutical and medical technology firms in this sector focus on the physiology of the gastrointestinal tract, developing targeted therapies for chronic inflammatory conditions, metabolic disorders, and functional motility issues.
As of Oct 23, 2026, Digestive Health has 16 US-listed companies worth $123B combined. The median member moved -1.1% over the past week; CV led at +7.0% and PHAT trailed at -17.1%.
Companies in Digestive Health
- BSX – Boston Scientific Corp, $66.7B
- HLN – Haleon plc, $45.6B
- MIRM – Mirum Pharmaceuticals Inc, $5.3B
- PBH – Prestige Brand Holdings Inc, $2.4B
- ARDX – Ardelyx Inc, $842M
- IRWD – Ironwood Pharmaceuticals Inc, $620M
- PHAT – Phathom Pharmaceuticals Inc, $551M
- CV – CapsoVision, Inc. Common Stock, $361M
- LWAY – Lifeway Foods Inc, $341M
- PALI – Palisade Bio Inc, $251M
- IMUX – Immunic Inc, $95.4M
- NRXS – Neuraxis, Inc., $87M
- TOVX – Theriva Biologics Inc., $9.9M
- IMRN – Immuron Ltd ADR, $9.4M
- ENSC – Ensysce Biosciences Inc, $7.8M
- KLDO – Kaleido Biosciences Inc, $4,262